The present invention relates to a novel form of (S)-1-[N.sup.2 -(1-carboxy-3-phenylpropyl]-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.

A invenção atual relaciona-se a um formulário da novela de (S)-1-[N.sup.2 -(1-carboxy-3-phenylpropyl]-L-lysyl]-L-proline sabido sob o lisinopril conhecido genérico. Mais mais, a invenção atual relaciona-se também ao uso do formulário amorfo da novela do lisinopril para o tratamento do hypertension e de outras doenças cardiovascular, composições pharmaceutical que contêm o as.well.as processos para a preparação do formulário amorfo da novela do lisinopril.

 
Web www.patentalert.com

< (none)

< Minimally-invasive access into the cochlea for electrode insertion and fluid delivery

> Antibodies to secreted protein HCEJQ69

> (none)

~ 00085